Cargando…

Therapeutic effects of an oral gonadotropin‐releasing hormone receptor antagonist, relugolix, on preventing premature ovulation in mild ovarian stimulation for IVF

PURPOSE: Can relugolix, a novel oral gonadotropin‐releasing hormone receptor (GnRH) antagonist, function as an alternative ovulation inhibitor to GnRH antagonist injections? METHODS: This single‐center, cross‐sectional retrospective study compared premature ovulation rates and clinical outcomes in I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakao, Kazuki, Kuroda, Keiji, Horikawa, Takashi, Moriyama, Azusa, Juen, Hiroyasu, Itakura, Akiko, Watanabe, Hideaki, Takamizawa, Satoru, Ojiro, Yuko, Nakagawa, Koji, Sugiyama, Rikikazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656665/ https://www.ncbi.nlm.nih.gov/pubmed/34938146 http://dx.doi.org/10.1002/rmb2.12422

Ejemplares similares

Impact of chronic endometritis on endometrial receptivity analysis results and pregnancy outcomes
por: Kuroda, Keiji, et al.
Publicado: (2020)

Effects of Periconceptional Multivitamin Supplementation on Folate and Homocysteine Levels Depending on Genetic Variants of Methyltetrahydrofolate Reductase in Infertile Japanese Women
por: Kuroda, Keiji, et al.
Publicado: (2021)

Therapeutic efficacy of gentle endometrial curettage on antibiotic‐resistant chronic endometritis in infertile women
por: Kuroda, Keiji, et al.
Publicado: (2023)

Comparison of Pregnancy Outcomes Between Fresh Embryo Transfer in a Natural IVF Cycle and IUI Cycle Among Infertile Young Women
por: Gekka, Yoko, et al.
Publicado: (2022)

Novel approaches to the management of recurrent pregnancy loss: The OPTIMUM (OPtimization of Thyroid function, Thrombophilia, Immunity, and Uterine Milieu) treatment strategy
por: Kuroda, Keiji, et al.
Publicado: (2021)

Transcriptomic profiling analysis of human endometrial stromal cells treated with autologous platelet‐rich plasma
por: Kuroda, Keiji, et al.
Publicado: (2023)

Clinical outcomes of assisted reproductive technology treatment by using a self‐injection of recombinant human chorionic gonadotropin as the final maturation trigger
por: Nakagawa, Koji, et al.
Publicado: (2018)

Hyaluronan-enriched transfer medium (HETM) can improve the implantation rate in morphologically poor euploid blastocyst transfer
por: Nakagawa, Koji, et al.
Publicado: (2023)

Clinical strategies for ART treatment of infertile women with advanced maternal age
por: Nakagawa, Koji, et al.
Publicado: (2018)

The novel oral gonadotropin‐releasing hormone receptor antagonist relugolix is a new option for controlled ovarian stimulation cycles
por: Komiya, Shinnosuke, et al.
Publicado: (2022)

After 12 consecutive miscarriages, a patient received immunosuppressive treatment and delivered an intact baby
por: Nakagawa, Koji, et al.
Publicado: (2017)

Induction of Ovulation in the Human with Human Gonadotropins
por: Buxton, C. Lee, et al.
Publicado: (1960)

Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Has the Same Effect as Gonadotropin-Releasing Hormone Agonist Injections in Terms of Preparation for Transcervical Resection Myomectomy
por: Ito, Mika, et al.
Publicado: (2022)

A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women
por: Lukes, Andrea, et al.
Publicado: (2023)

A novel orally active gonadotropin‐releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology
por: Hamada, Michiko, et al.
Publicado: (2021)

Gene expression signatures associated with chronic endometritis revealed by RNA sequencing
por: Oshina, Kyoko, et al.
Publicado: (2023)

Analysis of severe psychological stressors in women during fertility treatment: Japan-Female Employment and Mental health in Assisted reproductive technology (J-FEMA) study
por: Ikemoto, Yuko, et al.
Publicado: (2021)

Relugolix: A Review in Advanced Prostate Cancer
por: Shirley, Matt
Publicado: (2023)

Vitamin D Regulates Maternal T-Helper Cytokine Production in Infertile Women
por: Ikemoto, Yuko, et al.
Publicado: (2018)

A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy
por: Sasamori, Yukifumi, et al.
Publicado: (2021)

A case of lichenoid drug eruption associated with relugolix
por: Han, Joseph, et al.
Publicado: (2023)

Correction to: Relugolix: A Review in Advanced Prostate Cancer
por: Shirley, Matt
Publicado: (2023)

Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results
por: Osuga, Yutaka, et al.
Publicado: (2021)

Relugolix – The novel oral androgen deprivation therapy for prostate cancer
por: Jena, Rahul
Publicado: (2020)

Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas
por: Al-Hendy, Ayman, et al.
Publicado: (2022)

Human chorionic gonadotropin dose response for induction of ovulation 7 days after a synchronized ovulation in lactating Holstein cows
por: Cabrera, E.M., et al.
Publicado: (2020)

Prevention of Premature Ovulation by Administration of Gonadotropin Releasing Hormone Antagonist the day After Ovulation Triggering in Diminished Ovarian Reserve Patients
por: Sik, Bulat Aytek, et al.
Publicado: (2022)

Adjuvant Growth Hormone for Ovulation Induction with Gonadotropins in the Treatment of a Woman with Hypopituitarism
por: Daniel, Ariadne, et al.
Publicado: (2012)

Effects of echinomycin on endothelin-2 expression and ovulation in immature rats primed with gonadotropins
por: Wang, Zhengchao, et al.
Publicado: (2012)

Risk factors for resignation from work after starting infertility treatment among Japanese women: Japan-Female Employment and Mental health in Assisted reproductive technology (J-FEMA) study
por: Imai, Yuya, et al.
Publicado: (2021)

Characterization of tethered equine chorionic gonadotropin and its deglycosylated mutants by ovulation stimulation in mice
por: Min, Kwan-Sik, et al.
Publicado: (2019)

The use of gonadotropin-releasing hormone antagonist post-ovulation trigger in ovarian hyperstimulation syndrome
por: Chappell, Neil, et al.
Publicado: (2017)

Apolipoprotein B is regulated by gonadotropins and constitutes a predictive biomarker of IVF outcomes
por: Scalici, Elodie, et al.
Publicado: (2016)

Relugolix: A new kid on the block among gonadotrophin-releasing hormone antagonists
por: Fragkoulis, Charalampos, et al.
Publicado: (2021)

Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
por: Syed, Yahiya Y.
Publicado: (2022)

Characteristics of submucosal leiomyomas that could cause severe hemorrhage with relugolix: an observational study
por: Wada, Yoshimitsu, et al.
Publicado: (2023)

Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for Metastases
por: Brown, Gordon, et al.
Publicado: (2022)

A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy
por: Kasparian, Saro, et al.
Publicado: (2023)

Comparison of Two Regimens of Gonadotropin-releasing Hormone Antagonists in Clomiphene-gonadotropin Induced Controlled Ovulation and Intrauterine Insemination Cycles: Randomized Controlled Study
por: Karthik, Sajja Devendra Siva, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ugb9lhs7bc39po7vpq6j0aasmr